UNLIMITED TURBO SHORT - ELANCO ANIMAL HEALTH Stock

Certificat

DE000PC6JNN2

Market Closed - Boerse Frankfurt Warrants 15:50:26 2024-05-31 EDT
0.62 EUR -1.59% Intraday chart for UNLIMITED TURBO SHORT - ELANCO ANIMAL HEALTH
Current month-41.35%
1 month-41.35%
Date Price Change
24-05-31 0.61 -3.17%
24-05-30 0.63 -1.56%
24-05-29 0.64 -4.48%
24-05-28 0.67 -2.90%
24-05-27 0.69 -1.43%

Real-time Boerse Frankfurt Warrants

Last update May 31, 2024 at 03:50 pm

More quotes

Static data

Product typeCertificat Turbo
Buy / SellPUT
Underlying ELANCO ANIMAL HEALTH INCORPORATED
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC6JNN
ISINDE000PC6JNN2
Date issued 2024-03-12
Strike 24.07 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.78
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.09
Lowest since issue 0.61

Company Profile

Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
Sector
-
More about the company

Ratings for Elanco Animal Health Incorporated

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Elanco Animal Health Incorporated

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
17.68 USD
Average target price
19.11 USD
Spread / Average Target
+8.11%
Consensus